Table 6
Improvenents in exclusive STEMI group (2404 patients) over the whole cohort of 2594 patients | ||
|---|---|---|
1 | - Figure 1a improved by 2.4% | meaning less 3rd nitroglycerin’s were given in A9 compared to A1 (compared to whole cohort analysis) |
2 | Figure 1b improved by 2.16% | meaning more patients received only 1 nitroglycerin in group A9 compared to A1 (job was done with 1 nitroglycerin). (compared to whole cohort analysis) |
3 | Figure 2a improved by 0.76% | meaning more patients were feeling better (+) than same (0) in A9 compared to A1 in the combined 1st and 2nd nitroglycerin group. (compared to whole cohort analysis) |
4 | Figure 2b was reduced by 1.3% | meaning less patients were felling same (0), or more patients reported better (+) in A9 compared to A1 in the combined 3rd and the rest group. (compared to whole cohort analysis) |